% | $
Quotes you view appear here for quick access.

Titan Pharmaceuticals Inc. Message Board

  • settoplunge settoplunge Apr 11, 2013 4:56 PM Flag

    TTNP Should Apply For Expedited Review For Probuphine For Chronic Pain

    After approval on April 30th, Titan should run a small P2 trial and then file for expedited approval.

    Once the delivery system and buprenorphine for addiction is approved, extended trials won't be needed.
    If ACAD can file for expedited review for its pos drug, TTNP certainly should be able to.

    ACAD's market cap increased by $400M today on the news that they "plan" to file for expedited review.

    Come on Sunil, you've got cash now, start the Parkinson's and pain trials!
    Get off your fat butt, let's see some advancement of the pipeline.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
5.73-0.14(-2.39%)Sep 29 4:00 PMEDT